Cyclosporin nanosphere formulation for ophthalmic administration.
Khan W, Aldouby YH, Avramoff A, Domb AJ.
Khan W, et al.
Int J Pharm. 2012 Nov 1;437(1-2):275-6. doi: 10.1016/j.ijpharm.2012.08.016. Epub 2012 Aug 19.
Int J Pharm. 2012.
PMID: 22951866
CsA-NS formulation was characterized and adjusted for particle size, pH, and osmolarity, suitable for ophthalmic administration. Thereafter, CsA-NS formulation was evaluated for parameters like irritation to eyes and penetrability of CsA in the rabbit eyes. ...
CsA-NS formulation was characterized and adjusted for particle size, pH, and osmolarity, suitable for ophthalmic administration. Ther …